HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by HTG Molecular Diagnostics, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for HTG Molecular Diagnostics, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Barat Stephen | Senior VP of Therapeutics | 421 | Jun 9, 2023 | 0 |
| Lawson Byron | SVP/Chief Commercial Officer | 6,033 | Dec 13, 2022 | 0 |
| Lubniewski John L | President & CEO | 14,133 | Dec 13, 2022 | 0 |
| McMeans Shaun D | SVP, Finance & Admin. & CFO | 10,570 | Dec 13, 2022 | 0 |
| Godlewski Laura Lee | SVP Finance & Administration | 4,904 | Dec 13, 2022 | 0 |
| Hardison Don M | Director | – | Sep 15, 2022 | 0 |
| Griffin Michelle Renee | Director | – | Sep 15, 2022 | 0 |
| Kiritsy Christopher P | Director | – | Sep 15, 2022 | 0 |
| Hanham Ann | Director | – | Sep 15, 2022 | 0 |
| McCracken Lee R. | Director | – | Sep 15, 2022 | 0 |
| Dubensky Thomas W. | Director | – | Aug 22, 2022 | 0 |
| Lafrance James T | Director | – | Aug 19, 2021 | 0 |
| George Harry A. | Director | – | Aug 19, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 (view filing) | Jun 8 | 1 day | Barat StephenSenior VP of Therapeutics | SSale | −888 | $0.80 | −$710.4 | −67.8%421 after |